Kupryjanczyk J - Search Results

1

Adult height is associated with increased risk of ovarian cancer: a Mendelian randomisation study.

Dixon-Suen SC, Nagle CM, Thrift AP, Pharoah PDP, Ewing A, Pearce CL, Zheng W; Australian Ovarian Cancer Study Group; Chenevix-Trench G, Fasching PA, Beckmann MW, Lambrechts D, Vergote I, Lambrechts S, Van Nieuwenhuysen E, Rossing MA, Doherty JA, Wicklund KG, Chang-Claude J, Jung AY, Moysich KB, Odunsi K, Goodman MT, Wilkens LR, Thompson PJ, Shvetsov YB, Dörk T, Park-Simon TW, Hillemanns P, Bogdanova N, Butzow R, Nevanlinna H, Pelttari LM, Leminen A, Modugno F, Ness RB, Edwards RP, Kelley JL, Heitz F, du Bois A, Harter P, Schwaab I, Karlan BY, Lester J, Orsulic S, Rimel BJ, Kjær SK, Høgdall E, Jensen A, Goode EL, Fridley BL, Cunningham JM, Winham SJ, Giles GG, Bruinsma F, Milne RL, Southey MC, Hildebrandt MAT, Wu X, Lu KH, Liang D, Levine DA, Bisogna M, Schildkraut JM, Berchuck A, Cramer DW, Terry KL, Bandera EV, Olson SH, Salvesen HB, Thomsen LCV, Kopperud RK, Bjorge L, Kiemeney LA, Massuger LFAG, Pejovic T, Bruegl A, Cook LS, Le ND, Swenerton KD, Brooks-Wilson A, Kelemen LE, Lubiński J, Huzarski T, Gronwald J, Menkiszak J, Wentzensen N, Brinton L, Yang H, Lissowska J, Høgdall CK, Lundvall L, Song H, Tyrer JP, Campbell I, Eccles D, Paul J, Glasspool R, Siddiqui N, Whittemore AS, S… See abstract for full author list ➔ Dixon-Suen SC, et al. Among authors: kupryjanczyk j. Br J Cancer. 2018 Apr;118(8):1123-1129. doi: 10.1038/s41416-018-0011-3. Epub 2018 Mar 20. Br J Cancer. 2018. PMID: 29555990 Free PMC article.

2

Spontaneous apoptosis in ovarian carcinomas: a positive association with p53 gene mutation is dependent on growth fraction.

Kupryjańczyk J, Dansonka-Mieszkowska A, Szymańska T, Karpińska G, Rembiszewska A, Rusin M, Konopiński R, Kraszewska E, Timorek A, Yandell DW, Stelmachów J. Kupryjańczyk J, et al. Br J Cancer. 2000 Feb;82(3):579-83. doi: 10.1054/bjoc.1999.0967. Br J Cancer. 2000. PMID: 10682669 Free PMC article.

3

Nijmegen breakage syndrome gene (NBS1) alterations and its protein (nibrin) expression in human ovarian tumours.

Plisiecka-Hałasa J, Dansonka-Mieszkowska A, Rembiszewska A, Bidziński M, Steffen J, Kupryjańczyk J. Plisiecka-Hałasa J, et al. Among authors: kupryjanczyk j. Ann Hum Genet. 2002 Nov;66(Pt 5-6):353-9. doi: 10.1017/S0003480002001227. Ann Hum Genet. 2002. PMID: 12485469

4

TP53 status determines clinical significance of ERBB2 expression in ovarian cancer.

Kupryjańczyk J, Madry R, Plisiecka-Hałasa J, Bar J, Kraszewska E, Ziółkowska I, Timorek A, Stelmachów J, Emerich J, Jedryka M, Płuzańska A, Rzepka-Górska I, Urbański K, Zieliński J, Markowska J. Kupryjańczyk J, et al. Br J Cancer. 2004 Nov 29;91(11):1916-23. doi: 10.1038/sj.bjc.6602238. Br J Cancer. 2004. PMID: 15545967 Free PMC article.

5

PTEN mutation, expression and LOH at its locus in ovarian carcinomas. Relation to TP53, K-RAS and BRCA1 mutations.

Kolasa IK, Rembiszewska A, Janiec-Jankowska A, Dansonka-Mieszkowska A, Lewandowska AM, Konopka B, Kupryjańczyk J. Kolasa IK, et al. Among authors: kupryjanczyk j. Gynecol Oncol. 2006 Nov;103(2):692-7. doi: 10.1016/j.ygyno.2006.05.007. Epub 2006 Jun 21. Gynecol Oncol. 2006. PMID: 16793127

6

Geographical variations in TP53 mutational spectrum in ovarian carcinomas.

Dansonka-Mieszkowska A, Ludwig AH, Kraszewska E, Kupryjańczyk J. Dansonka-Mieszkowska A, et al. Among authors: kupryjanczyk j. Ann Hum Genet. 2006 Sep;70(Pt 5):594-604. doi: 10.1111/j.1469-1809.2006.00257.x. Ann Hum Genet. 2006. PMID: 16907706

7

CHFR gene is neither mutated nor hypermethylated in ovarian cancer.

Ludwig AH, Bujko M, Bidzinski M, Kupryjańczyk J. Ludwig AH, et al. Among authors: kupryjanczyk j. Cancer Detect Prev. 2007;31(3):257-61. doi: 10.1016/j.cdp.2006.04.005. Epub 2007 Jul 30. Cancer Detect Prev. 2007. PMID: 17673375

8

Human papillomavirus infection in women with and without cervical cancer in Warsaw, Poland.

Bardin A, Vaccarella S, Clifford GM, Lissowska J, Rekosz M, Bobkiewicz P, Kupryjańczyk J, Krynicki R, Jonska-Gmyrek J, Danska-Bidzinska A, Snijders PJ, Meijer CJ, Zatonski W, Franceschi S. Bardin A, et al. Among authors: kupryjanczyk j. Eur J Cancer. 2008 Mar;44(4):557-64. doi: 10.1016/j.ejca.2007.12.001. Epub 2008 Jan 11. Eur J Cancer. 2008. PMID: 18191395

9

Loss of heterozygosity, microsatellite instability and TP53 gene status in ovarian carcinomas.

Plisiecka-Hałasa J, Dansonka-Mieszkowska A, Kraszewska E, Dańska-Bidzińska A, Kupryjańczyk J. Plisiecka-Hałasa J, et al. Among authors: kupryjanczyk j. Anticancer Res. 2008 Mar-Apr;28(2A):989-96. Anticancer Res. 2008. PMID: 18507046 Free article.

10

PIK3CA amplification associates with resistance to chemotherapy in ovarian cancer patients.

Kolasa IK, Rembiszewska A, Felisiak A, Ziolkowska-Seta I, Murawska M, Moes J, Timorek A, Dansonka-Mieszkowska A, Kupryjanczyk J. Kolasa IK, et al. Among authors: kupryjanczyk j. Cancer Biol Ther. 2009 Jan;8(1):21-6. doi: 10.4161/cbt.8.1.7209. Epub 2009 Jan 17. Cancer Biol Ther. 2009. PMID: 19029838 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

128 results

Search Page

Filters